A single dose of a Covid-19 vaccine triggers an immune response in around 70 per cent of patients with myeloma – suggesting that it does provide protection against the virus.

A new drug designed to counter the effects of an important, but very hard to target, cancer mutation could be effective against a range of tumour types including lung and gynaecological cancers, a new clinical trial shows.

A new genetic test could help doctors pick out patients with the bone marrow cancer multiple myeloma who are at ‘ultra high risk’ of their cancer progressing aggressively early on.